This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Amgen Inc.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: The Innovations of Peng Li
Introduction
Peng Li is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, holding 2 patents that reflect his innovative spirit and dedication to advancing scientific knowledge.
Latest Patents
His latest patents include "Inhibitory polypeptides specific to WNT inhibitors," which focuses on avimers and peptides, along with methods for their production and application. Another significant patent is for "Binding proteins that bind to human FGFR1C, human β-klotho, and both human FGFR1C and human β-klotho." This patent provides binding proteins that specifically interact with β-Klotho or FGFR1c, along with coding sequences, treatment methods, and pharmaceutical compositions.
Career Highlights
Peng Li is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to contribute to groundbreaking research and development in the field.
Collaborations
He collaborates with talented coworkers, including Alice Bakker and Amy N Duguay, who share his commitment to innovation and excellence in research.
Conclusion
Peng Li's contributions to biotechnology through his patents and work at Amgen Inc. highlight his role as a key innovator in the field. His ongoing research continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile